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Despite strong efforts in the field, spinal cord trauma still belongs among the untreatable neurological conditions at present. 
Given the complexity of the nervous system, an effective therapy leading to complete recovery has still not been found. One of 
the potential tools for supporting tissue regeneration may be found in mesenchymal stem cells, which possess anti‑inflammatory 
and trophic factor‑producing properties. In the context of transplantations, application of degradable biomaterials which could 
form a supportive environment and scaffold to bridge the lesion area represents another attractive strategy. In the present study, 
through a  combination of these two approaches we applied both alginate hydrogel biomaterial alone or allogenic transplants 
of MSCs isolated from bone marrow seeded in alginate biomaterial into injured rat spinal cord at three weeks after spinal cord 
compression performed at Th8‑9 level. Following three‑week survival, using immunohistochemistry we studied axonal growth 
(GAP‑43 expression) and both microglia (Iba‑1) and astrocyte (GFAP) reactions at the lesion site and in the segments below and 
above the lesion. To detect functional improvement, during whole survival period we performed behavioral analyses of locomotor 
abilities using a  classical open field test (BBB score) and a  Catwalk automated gait analyzing device (Noldus). We found that 
despite the absence of locomotor improvement, application of both alginate and MSCs caused significant increase in the number 
of GAP‑43 positive axons. 
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INTRODUCTION
Spinal cord injury is a serious health condition which 
in spite of extensive research in the field lacks any ef‑
fective treatment leading to complete recovery of lost 
motor and sensory functions. Several approaches with 
reported potential therapeutic effect have been studied 
including surgical interventions (van Middendorp et al. 
2012), pharmacology (Blight and Zimber 2001), hypo‑
thermia (Grulova et al. 2013), physical exercise (Ying 
et al. 2008, Foret et al. 2009) or cell transplantation 
(Ritfeld et al. 2012). Experimental therapeutic inter‑
ventions are intended to influence secondary damage 
processes such as inflammation, inhibition of molecule 
formation, edema or apoptosis to prevent further dam‑
age in the tissue (Tator 1995). Despite the necessity of 
taking all of these components into account as a sin‑
gle comprehensive condition for future therapeutic 
efforts, detailed studies of above‑mentioned individual 
events still remain important. Inflammation, as a nat‑
ural response of the tissue to injury, is one of the most 
important processes occurring after SCI, characterized 
by infiltration of activated immune cells and edema 
formation with consequent devastating impact on the 
intact nervous tissue (Donnelly and Popovich 2008). In 
general, with its prevailing negative effects, inflam‑
mation has become of key target of experimental and 
clinical treatment. Mesenchymal stem cells (MSCs) rep‑
resent an interesting tool with considerable potential 
in this context. Several studies have produced evidence 
about the capacity of these cells not only to suppress 
immune response (Aggarwal and Pittenger 2005) but 
also to produce neurotrophic (Zhang et al. 2003) and 
vascular factors (Hamano et al. 2000). In the context of 
transplantation and pharmacological therapies, anoth‑
er attractive strategy has emerged in recent years. Ap‑
plication of degradable biomaterials enriched with cells 
or various factors has been described as very promising 
(Suzuki et al. 2002, Nomura et al. 2006, Grulova et al. 
2015). There are several potential benefits of using bio‑
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materials, one of the most important being that bio‑
materials such as alginate have the capacity to fill cav‑
ities and thus offer physical support for newly‑formed 
regenerating tissue including axonal processes (Suzuki 
et al. 2002, Nomura et al. 2006). Similarly, biomateri‑
al scaffolds could form microenvironments for trans‑
planted cell populations, enabling sustainable release 
of supporting factors (Wang et al. 2008). 
In the present study we applied alginate hydrogel 
alone or seeded with MSCs isolated from bone mar‑
row into the injured rat spinal cord at three weeks 
after SCI. To detect functional improvement, during 
the whole survival period we performed behavior‑
al analyses of locomotor abilities in a classical open 
field test (BBB score) and with a Catwalk automated 
gait analyzing device (Noldus). After three weeks us‑
ing immunohistochemistry we studied axonal growth 
and both microglia and astrocyte reactions at the le‑
sion site and in segments below and above the lesion. 
We found that despite intergroup differences in axo‑
nal sprouting and both microglia and astrocyte num‑
bers, these changes were not significantly reflected in 
behavioral outcomes. 
METHODS
Animals
Adult male Wistar albino rats (300‑330g), were divided 
into four groups: intact controls (n=5), sci/saline (n=5), rats 
treated with alginate – sci/Alg/‑ (n=5), rats treated with 
alginate+MSCs sci/Alg/MSCs (n=6). 
Compliance with Ethical Standards
This study was carried out with the approval and 
according to the guidelines of the Institutional Animal 
Care and Use Committee of the Slovak Academy of Sci‑
ences and with the European Communities Council Di‑
rective (2010/63/EU) regarding the use of animals in re‑
search and Slovak Law for Animal Protection 377/2012 
and 436/2012. Totally 21 adult male Wistar albino rats 
were used in this study.
Spinal cord injury
Moderate spinal cord injury was induced by mod‑
ified balloon‑compression according to Vanicky 2001. 
Briefly, rats were first put under anesthesia with 1.5% 
to 2% isoflurane. Then 2‑French Fogarty catheter was 
inserted epidurally at Th8–Th9 level of the vertebral 
column and the balloon was inflated with 12.5 µl of sa‑
line for 5 minutes. After 5 minutes the catheter was de‑
flated and removed from the vertebral canal. Selected 
volume of balloon compression caused initial complete 
paraplegia followed by gradual recovery of locomotion. 
First 3–7 days after surgery, manual bladder expression 
was performed twice a day until the bladder control 
was regained. Postoperational care did not involve an‑
tibiotic or analgetic treatment. 
Preparation of alginate scaffold 
Alginate biomaterial was prepared according to 
previously reported protocols (Tsur‑Gang et al. 2009, 
Grulova et al. 2015). Briefly, solutions of sodium algi‑
nate (VLVG, 30‑50 kDa, >65% guluronic acid content, 
NovaMatrix FMC Biopolymers, Drammen, Norway) and 
D‑gluconic acid/hemi calcium salt were prepared by 
dissolving these components in double‑distilled wa‑
ter and stirring at room temperature. Then, both solu‑
tions were filtered separately through a sterile 0.2 μm 
filter membrane into a sterile dish in a tissue culture 
hood. To prepare partially calcium‑cross linked algi‑
nate, equal volumes from each stock solution (2.08% 
and 0.64% (w/v) for VLVG alginate and D‑gluconic acid, 
respectively) were combined by extensive homogeniza‑
tion for several minutes to facilitate homogenous dis‑
tribution of the calcium ions and cross linking of algi‑
nate chains. 
MSCs isolation and cultivation
Bone marrow was isolated from the femur and tib‑
ia of adult male Wistar rats (300 g) after terminal an‑
esthesis (thiopental, 50 mg/kg, i.p.) as described in 
our previous work (Nagyova et al. 2014). Whole bone 
marrow was flushed with ice‑cold saline solution and 
dissected into small pieces on ice. The tissue was then 
homogenized and centrifuged at 400×g for 10 min. The 
obtained cell pellet (containing both hematopoietic 
cells and marrow mesenchymal cells) was resuspend‑
ed; plated on a 75‑ cm2 flask; cultured in 13 ml of cul‑
ture medium containing Minimum Essential Medium 
(MEM) (Biowest, Nuaillé, France), 15% fetal bovine 
serum (FBS) (Biowest), and 1% penicillin‑streptomy‑
cin (Biochrom AG, Berlin, DE); and incubated at 37°C 
in a humidified atmosphere with 5% CO2. Nonadherent 
cells were removed after 48 h by change of the me‑
dium. Upon reaching 90% confluence, the cells were 
passaged using 0.05% trypsin‑EDTA (Gibco; Invitrogen, 
Carlsbad, CA) and plated on culture flasks at a density 
of 0.7×106/75 cm2. 
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Fenotypic characterization of bone marrow MSCs 
by flow cytometry
The fenotypic expression of CD90, CD29, and the ab‑
sence of CD 45 at passage 3 was analysed. Following an‑
tibodies for flow cytometry were used according to the 
suppliers recomendations: PE anti‑rat CD90 (BioLegend), 
PE anti‑rat CD45 (BioLegend), PE anti‑mouse/rat CD29 
(BioLegend). Samples were processed through a FACS 
Calibur (BD Bioscience) operated by CellQuest software.
Membrane labeling of MSCs with PKH67
Prior to the intraspinal delivery, the MSCs were la‑
beled with green fluorescent cell marker PKH67 accord‑
ing to the previously published protocol (Wallace et al. 
2008, Nagyova et al. 2014). Briefly, immediately prior to 
staining procedure, PKH67 dye (Sigma) was prepared 
and added to 1 ml of resuspended MSCs (2×106 cells). Af‑
ter 20 min incubation at 25°C, an equal volume of α‑MEM 
with 1% FBS was added to stop the staining reaction. 
In vitro cultivation of PKH67 labeled MSCs  
in alginate
At day of in vivo application, PKH67 labeled MSCs in 
alginate (16 µl) were separated and cultivated in 4 well 
dishes (4 µl/well) with α‑MEM, 10% FBS and 1% penicil‑
lin‑streptomycin at 37°C for 3 weeks. After this period, 
to verify the intensity of PKH67 signal, cells were ob‑
served under inverted fluorescent microscope (Nikon 
Eclipse Ti). 
Intraspinal delivery of alginate and MSCs
Three weeks after SCI, animals were anesthetized 
with 1.5–2% isoflurane and to expose the spinal cord, 
a partial laminectomy at Th6‑12 level was performed. 
Using a 50‑μl Hamilton syringe (27G needle, 9 Cole Par‑
mer, Anjou, Quebec) connected to UltraMicroPump III 
with Micro4 Controller, 4‑Channel (World Precision In‑
struments, Inc., Sarasota FL) and stereotactic device, 
6 intraspinal injections with saline or alginate or algi‑
nate/MSCs per animal (4 µl/injection) were applied into 
the lesion site that showed discreet signs of damage. The 
number of MSCs in alginate/MSCs group represented 
approximately 1.3×105 cells per microliter. Bilateral de‑
livery of i) saline, ii) ALG, or iii) ALG/MSCs with deliv‑
ery rate of 0.5 μl/min was performed. Each injection was 
positioned 1mm from the spinal cord midline avoiding 
spinal blood vessels and applied at the depth of 1.8‑2mm 
from the surface of the spinal cord. The distance be‑
tween injections was 1mm. After each injection, the nee‑
dle was kept in the tissue for an additional 30 seconds. 
Rats received no antibiotic treatment after surgery.
Behavioral testing
Open field test – BBB score
Behavioral testing was performed by using BBB open 
field locomotor test (Basso et al. 1995), measuring re‑
covery of locomotor functions before SCI procedure 
(baseline) and immediately after SCI at days 0, 7, 14, 21 
post‑injury and after treatment. BBB score represents 
21‑point open field locomotor scale, where 0 reflects no 
locomotion and 21 normal motor functions. Each rat was 
observed for 5 minutes by two blinded observers; rat’s 
hindlimb movements, trunk position and stability, step‑
ping, coordination, paw placement, toe clearance, and 
tail position were analyzed during evaluation period. 
The values of both hindlimbs were averaged.
Catwalk
In the present study we used the CatWalk gait anal‑
ysis system (Catwalk XT version 10.0; Noldus) for more 
objective evaluation of hindlimb motor activity. Animals 
were familiarized and trained on the Catwalk glass walk‑
way (62x11.3 cm) 2 weeks prior to surgery as previously 
described (Hamers 2001). Pre‑operative measurements 
were performed one week before surgery. Then, each as‑
sessment was realized first week after surgery, when rats 
regained capacity of plantar stepping of the hindpaws. 
Three runs were analyzed from each animal in each stud‑
ied period (7, 14 and 21 days after injury and at 7, 14 and 
21 days after treatment). Only runs with the duration be‑
tween 2–5 seconds were taken into account. The values of 
both hindlimbs were averaged. In our study we assessed 
these 8 parameters: stand duration, swing duration, swing 
speed, stride length, mean intensity and regularity index, 
which have been evaluated in previous experiments us‑
ing various spinal cord injury models (Hamers et al. 2001, 
Vrinten and Hamers 2003, Joosten et al. 2004, Klapka et al. 
2005, Kloos et al. 2005, Hendricks et al. 2006, Koopmans et 
al. 2007, Galvan et al. 2008). For statistical analysis one‑way 
ANOVA followed by Tukey’s post hock tests was used. 
Tissue processing and immunohistochemistry
After a 21 day survival period, animals were deeply 
anesthetized by intraperitoneal injection of thiopental 
(50 mg/kg) and transcardially perfused with 500 ml saline, 
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followed by 500 ml of 4% paraformaldehyde (PFA) in 0.1M 
phosphate‑buffer (PB). Spinal cords were removed from 
vertebral canals, postfixed in 4% PFA at 4°C overnight, em‑
bedded in gelatin‑egg albumin protein matrix (10% ovalbu‑
min, 0.75% gelatine) polymerized by glutaraldehyde (albu‑
min from chicken egg white, grade II, Sigma–Aldrich) fixed 
in 4% PFA, and cryoprotected with 30% sucrose in 0.1M PB 
at 4°C. Cryostat transversal spinal cord sections (40 μm) 
were cut from rostral, lesion or caudal segments (each 
1 cm long) and collected in 12‑well plates with 0.1M PBS 
containing 0.1% sodium azide. For immunohistochemistry, 
free floating sections (40 μm) were incubated in PBS (0.1 M; 
pH 7.4) with 10% normal goat serum (NGS) and 0.2% Triton 
X‑100 for 2 hours at room temperature to block non‑specif‑
ic reaction. Sections were then incubated overnight (4°C) 
with primary antibodies: mouse anti‑synaptophysin (SYN; 
1: 500, Merck‑Millipore), mouse anti‑ glial fibrillary acidic 
protein (GFAP; 1: 1000, Merck‑Millipore) rabbit anti‑GAP‑43 
(1: 1000, Merck‑Millipore), rabbit anti‑Iba‑1 (1: 500, Wako). 
Next, sections were rinsed in 0.1 M PBS and incubated with 
secondary fluorescent antibodies Texas Red (Alexa Flour 
594) for 1 hour or fluorescein isothiocyanate (FITC) (Alexa 
Flour 488) at room temperature for 2 hours. For general 
nuclear staining 4‑6‑diaminidino‑2‑phenylindol (DAPI; 1: 
200) was added to the final secondary antibody solutions. 
In the final step, sections were mounted and coverslipped 
with Vectashield mounting medium (Vector Laboratories).
Quantification analyses
Sections were analyzed using confocal (Leica DM1500) 
or fluorescent microscope (Olympus BX‑50) and quanti‑
fication performed by ImageJ software. Five sections per 
animal were analyzed for each staining in rostral, lesion 
and caudal segments (15 sections per animal) except of 
GAP‑43 staining in which only lesion segment was consid‑
ered. Iba‑1 positive microglia cells were counted manual‑
ly in 5 randomly selected squares of a grid. GFAP positivi‑
ty was evaluated as a percentage of black pixels in overall 
image. Images were first transformed into monochromat‑
ic 8‑bit images and then threshold was adjusted to opti‑
mal value after visual comparison of the original images. 
The length of GAP‑43 positive axons was measured man‑
ually in 5 sections from each animal and the result rep‑
resents the average length for each experimental group. 
Fig. 1. PKH67 labeled floating cells after seeding in alginate in vitro at day of application (A) and after 3 weeks (B). Although cell density decreased in time, 
PKH67 signal intensity remained unchanged. Note the change in cell morphology due to cell adhesion. Scale bar 100 µm. C: Fenotypic characterization of 
bone marrow MSCs : expressed 99.37% CD90; 99.43% CD29 and 14.98% CD45.
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The orientation of GAP‑43 positive axons was analyzed 
by recently developed AngleJ plugin of ImageJ software 
(Gunther et al. 2015a) in 8‑bit gray scale images at 20x 
magnification. Measured angles were pooled into 36 bins 
between ‑90° and 90°. The orientation of GAP‑43 positive 
axons is expressed in a range of 180°, with 0° represent‑
ing the longitudinal (rostro‑caudal) axis of the spinal cord 
and ‑90°/90° representing the mediolateral direction.
Data and statistical analysis
Data from tissue analyses and behavioral testing 
were reported as mean ±SEM. Mean values among differ‑
ent experimental groups were statistically compared by 
one‑way ANOVA and Tukey’s post hock tests using Graph 
pad PRISM software. Values of P<0.05 were considered 
statistically significant (*P value of <0.05, **P value of 
<0.01, ***P<0.001).
RESULTS
Characterisation of bone marrow MSCs
Flow cytometry analysis (Fig. 1C) have shown that 
MSCs at passage 3 were positive for mesenchymal stem 
cells markers (99.37% CD90 and 99.43% CD29) and nega‑
tive for hematopoietic marker CD45 (14,98% ).
Durability of PKH67 staining and the presence of 
transplanted PKH67+ mesenchymal stem cells at 
lesion site
To test and compare the durability of PKH67 stain‑
ing in vitro vs. in vivo, cultivation of PKH67+ MSCs was 
performed in parallel with the in vivo experiment. After 
3 week cultivation in alginate biomaterial, labeled MSCs 
exhibited strong PKH67 positivity although cell density 
significantly dropped (Fig. 1A, B). In vivo, PKH67+ MSCs 
exhibited round‑shaped morphology and were mostly 
localized in clusters with slight sings of migration from 
the injection site in both rostral and caudal direction 
(Fig. 2). 
Behavioral analysis
Two behavioral tests were performed during ani‑
mal survival. In all groups, progressive locomotor re‑
covery was seen throughout the survival period. In all 
treated groups, significant decrease in BBB scale and 
change in catwalk parameter was observed after treat‑
ment procedure.
BBB score
All animals were tested for their locomotor per‑
formance in an open field test 24 hours after SCI, 
Fig. 2. (A, B) Transplanted MSCs PKH67+ cells at the lesion site three weeks after application. (A) Scale bar 200 µm, (B) 40 µm.
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and then every 7th day. The outcomes expressed as 
BBB scores are shown in Fig. 3. One day after injury, 
compression caused total hindlimb paralysis with no 
movement. Following 21 days, animals in all three 
groups with injury showed similar gradual recovery 
of locomotion together with improved urination. On 
the 21st day, before application of either alginate or 
alginate with MSCs animals showed BBB score with‑
out significant difference between groups (sci/saline 
12±1.4; sci/Alg 12.5±0.8; sci/Alg/MSCs 13±3.8; p=0,806). 
7 days after treatment we found decrease in BBB scale 
(sci/saline 9±1.4; sci/Alg 9.5±2.1; sci/Alg/MSCs 10±5.1; 
p=0,892) due to treatment procedure which was typi‑
cal for all animals. In next two weeks, animals showed 
gradual improvement of locomotion but without sig‑
nificant differences between groups. For each time 
point, one‑way ANOVA followed by Tukey’s post hock 
tests was used. 
Catwalk
Following gait parameters were evaluated in this 
study (Fig. 4): 
Stand duration – the time (s) of contact of the hind‑
paw with the glass surface of the instrument. This 
parameter remained relative settled in intact group 
and without significant changes in sci/Alg or sci/alg/
MSCs treated rats. The temporary increase in sci/saline 
(0.368±0.02 s) group at 7 days after SCI was followed by 
gradual decrease with significant difference (p=0.013) 
at 28 (0.22±0.09), 35 (0.17±0.07) and 42 (0.19±0.09) days 
after SCI compared to the 7 day interval. At 7 days after 
SCI, the values of stand duration were highest in sci/
saline group when compared to sci/Alg or sci/alg/MSCs 
treated rats, however without significant differenc‑
es (intact control 0.26±0.08, sci/saline 0.36±0.02; sci/Alg 
0.28±0.0.08; sci/Alg/MSCs 0.28±0.09; p=0.834). Alginate 
and alginate/MSCs group did not show any significant 
fluctuations in stand duration parameter during the 
whole studied period. 
Swing duration – the time (s) that the hindpaw is not 
in the contact with the glass surface. This parameter did 
not show any significant changes between groups or in 
time perspectives. 
Swing speed – a ratio of stride length and swing du‑
ration reflecting the speed (mm/s) of the paw during 
swing phase. Here we found higher values in sci/saline 
group starting 14 days after SCI and continuing up to 
42th days when compared to sci/Alg or sci/alg/MSCs 
animals. Significant difference between sci/saline and 
sci/Alg/MSCs rats was observed at 28days (sci/saline 
148±24.4; sci/Alg/MSCs 95.54±21.33; p=0.015) and 42 days 
(sci/saline148±24.4; sci/Alg/MSCs 94.54±16.75; p=0.003) 
after SCI.
Stride length – the distance (cm) between two sub‑
sequent placements of the particular hindpaw. In this 
gait parameter sci/saline animals exhibited the highest 
values in all studied periods. At 42 days we found sig‑
nificant difference between sci/saline versus sci/Alg/MSCs 
(12.52±2.63) animals (p=0.009). In sci/Alg and sci/Alg/MSCs 
animals, the values of stride length remained relative 
stable and unchanged during the whole experiment.
Mean intensity – the mean intensity of paw contact 
with glass surface in pixels. This parameter did not ex‑
hibit any significant differences between groups after 
SCI or after treatment. Slight non‑significant increase 
was observed at 21, 28 and 35 day in sci/Alg rats. 
Regularity index – the number of normal step se‑
quence patterns (%) relative to the total number of 
paw placements, reflects the degree of interlimb coor‑
dination during gait. It is described as a ratio between 
normal step sequence patterns and the total number 
of paw placements during gait. In healthy animals the 
value of regularity index is close to the 100% (Hamers 
et al. 2001). All groups of animals had regularity index 
within the range of 96‑98% before the injury (intact 
control 96±10; sci/saline 98.72±9.85; sci/Alg 96.81±1.63; 
sci/Alg/MSCs 97.51±2.08). Spinal cord injury caused 
significant decrease of interlimb coordination in all 
experimental groups which was obvious at first week 
after the impact. We found significant decrease at 
7 days after injury in sci/saline (79.2±10.7; p=0.03), sci/
Alg (77.83±12.82; p=0.04) and sci/Alg/MSCs (72.1±10.1; 
p=0.06) rats. At 14 days we observed slight non sig‑
nificant increase suggesting regeneration. However 
treatment with alginate and alginate/MSCs also had 
an influence on this parameter. At 21 days after SCI, i. 
e. the first week after treatment we found significant 
decrease in sci/Alg/MSCs (73.54±8.26; p=0.006) animals 
and at 35 days after SCI regularity index was decreased 
in both sci/Alg (78.15±10.7; p=0.04) and sci/Alg/MSCs 
(74.43±15.94; p=0.06).
Fig. 3. BBB score. Gradual recovery of hindlimbs functions. Only small non 
significant improvement was observed in groups treated with alginate or 
alginate/MSCs. For each time point, one‑way ANOVA followed by Tukey’s 
post hock tests was used. 
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Immunohistochemistry
Axonal outgrowth and orientation
For evaluation of axonal regeneration at the lesion 
site (L „segment“), we used GAP‑43 antibody. In all an‑
imal groups, with the exception of intact control rats, 
we observed GAP‑43 positive fibers distributed in all ex‑
tent of the L segment predominantly in the proximity 
of cavities. GAP‑43 positive axons never spread through 
cavities with lacking spared tissue. However, with‑
in all groups with GAP‑43 positive axons, we observed 
Fig. 4. Catwalk gait analysis of hindlimb locomotion. We have evaluated six gait parameters which have been previously described as relevant for spinal cord 
injury: Stand duration – the time (s) of contact of the hindpaw with the glass surface; Alginate and alginate/MSCs group did not show any significant fluctuations 
during the whole studied period. Only significant differences were found in sci/saline animals at 28, 35 and 42 days after injury when compared to values at 7 day 
which were transiently increased. Swing duration – the time (s) that the hindpaw is not in the contact with the glass surface; This parameter did not show any 
significant changes or intergroup differences in any time interval. Stride length – the distance (cm) between two subsequent placements of the particular hindpaw; 
Here we found significantly higher value at 42 days in rats injected with saline compared to alginate/MSCs treated animals. However, saline animals had this 
parameter higher during majority of studied intervals. Swing speed – a ratio of stride length and swing duration reflecting the speed (mm/s) of the paw during 
swing; At 28 and 42 day after SCI, rats in saline group showed significantly higher values compared to Alg/MSCs treated animals. Similarly to the stride length 
parameter, here saline rats also exhibited relative high values during whole experiment. Mean intensity – intensity of paw contact with glass surface in pixels; Here, 
only slight non‑significant increase was observed at 21, 28 and 35 day in alginate treated rats. Regularity index – the number of normal step sequence patterns (%) 
relative to the total number of paw placements, reflects the degree of interlimb coordination during gait. Here we found significant drop in all groups with SCI on 
the first week after injury. After transient recovery, regularity index decreased again as a consequence of alginate or alginate/MSCs treatment – 21 and 35 days 
after SCI. Data are represented as mean ± SEM. *P<0.05, **P<0.01, ***P <0.001, one‑way ANOVA followed by Tukey‑Kramer test.
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remarkable variability between animals. Interesting‑
ly, quantification (Fig. 5) has revealed that the high‑
est extent of outgrowing axons was present in sci/Alg/
MSCs (5967.52±1059 µm) which was significantly higher 
(p<0.001) than in rats with alginate (1700.5±390.8 µm) 
or sci/saline (1647.6±386.75µm). GAP‑43 positive axons 
clearly spread into the lesion site often in close proxim‑
ity to transplanted cells. Analysis of axonal outgrowth 
orientation (Fig. 6) showed that most GAP43+ axons had 
tendency to grow in rostrocaudal orientation with 29% 
of axons angles within range of ±10° and 48% within 
range of ±20° in group with transplanted cells; 28% of 
axons angles within range of ±10° and 47% within range 
of ±20° in sci/Alg group and 28% of axons angles within 
range of ±10° and 46% within range of ±20° in rats treated 
with saline. 
Quantification of astrocytes
GFAP positive cells (Fig. 7 A‑H) were quantified 
separately in rostral (R), lesion (L) and caudal (C) 
segments in both the grey (Fig. 7 I) and white mat‑
ter (Fig. 7 J). When comparing R, L and C segments in 
the grey matter, we observed slightly increasing, but 
not significant GFAP positivity in rostro‑caudal di‑
rection in all groups of animals. Regarding individual 
segment differences at rostral segment, in all groups 
with SCI (sci/saline 26 ±1.71; sci/Alg/‑ 29.67±3.5; sci/Alg/
MSCs 28.5±5.3) there was highly significant (p=0.009; 
p=0.0009) increase in GFAP density compared to intact 
control (18.5±1). The same pattern was found at lesion 
and caudal segment. At lesion segment GFAP expres‑
sion significantly (p=0.048; p=0.0009) increased in SCI 
Fig. 5. Quantification of GAP‑43 positive axons at the lesion site in three experimental groups with SCI and intact control. Intact animals showed no 
GAP‑43 positivity within the whole extent of the spinal cord (A‑A’). The highest axonal sprouting was found in the group treated with both alginate and 
MSCs (D‑D’, F). The similar expression of GAP‑43 was found in the group treated with saline and in the group with alginate (B‑B’,C‑C’, E). (G) total length 
of GAP‑43 positive axons among experimental groups. Data are represented as mean ±SEM. ***P<0.001, one‑way ANOVA followed by Tukey‑Kramer 
test. Figs (A‑D) (whole spinal cord sections) scale bar 1000 µm, (A’‑D’) (magnified areas from A‑D) scale bar 200 µm. (E‑F) representative pictures of 
GAP‑43 positive axons in two experimental groups, scale bar 25 µm. 
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animals (sci/saline 28.1±1; sci/Alg/‑ 35.5±6.02; sci/Alg/
MSCs 34.6±5.74) comparing to intact control (19.3±2.44) 
which was similar to caudal segment (intact control 
20.3±2.97; sci/saline 29.1±2.1; sci/Alg/‑ 35.4±8.1; sci/Alg/
MSCs 39.7±7.63; p=0.046). In the white mater we did not 
find any significant change in GFAP expression after 
SCI or treatment except of sci/saline group (36.6±4.7) 
versus intact control group (17.7±4.01; p=0.006) in the 
lesion segment and sci/saline vs. sci/Alg/‑ (21.3±6.3; 
p=0.009) .
Microglia quantification
Similarly to astrocytes quantification, number of 
Iba‑1 positive microglia was evaluated in R, L and C seg‑
ments of the spinal cord in both grey and white mat‑
ter. In all three segments, it was obvious that injury 
caused increase in the number of microglia cells in the 
grey matter (Fig. 8 H) in each group with trauma. At ros‑
tral segment we observed significant (p=0.03) increase 
between intact control (3±1) and sci/Alg/‑ (14.14±2.11). 
Lesion segment exhibited the highest number of Iba‑1 
microglia compared to rostral and caudal segments. 
Here, we found significant increase in all three groups 
with trauma (sci/saline 25±7.44; p=0.0007), (sci/Alg/‑ 
21.8±3.78;p=0.0059), sci/Alg/MSCs (17.8±8.42; p=0.018) 
compared to intact controls (5.6±1.15). Similar pattern 
was observed at the caudal segment, where significant 
increase was detected in sci/saline (17.25±4.79; p=0.014) 
and sci/Alg/‑ (21.6±7.77; p=0.0008) in comparison to intact 
control (4±1). In the white mater (Fig. 8 I) we found sig‑
nificant differences between intact control (3.3±1.53) and 
sci/Alg/‑ (12.67±3.83; p=0.0007) at the lesion segment and 
between the same groups at the caudal segment (intact 
control 4±1; sci/Alg/‑15.83±4.3; p=0.0007).
DISCUSSION
Axonal outgrowth
In this study we investigated both behaviorally and 
immunohistochemically the effects of alginate or algi‑
nate/MSCs treatment on injured spinal cord in rats. One 
of the key parameters studied here was the outgrowth of 
regenerating axons, which we evaluated in the lesion seg‑
ment using the GAP‑43 antibody. In accord with previous 
reports (Curtis et al. 1993, Novotna et al. 2011) we did not 
Fig. 6. Orientation of regenerating GAP‑43 positive axons at the lesion site. Axons in all three groups of animals exhibiting GAP‑43 positivity are oriented 
mostly in longitudinal (rostrocaudal) direction.
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detect any GAP‑43 positive axons in the group of intact 
rats. On the other hand, in all groups with SCI we found 
relatively high levels of GAP‑43 positivity. This finding 
confirms that the expression of this protein is closely re‑
lated to damage of the neural tissue, or possibly with en‑
dogenous regenerative processes (Linda et al. 1992). The 
highest presence of axonal outgrowth was found in ani‑
mals in which the combination of biomaterial and MSCs 
was applied. Numbers of GAP‑43 positive axons in groups 
with alginate alone or saline were approximately at the 
same level. The common sign in all animal groups with 
the presence of regenerating axons was that GAP‑43 pos‑
itive fibers were exclusively present in those parts of the 
lesion where at least a small amount of tissue remained. 
In other words, axons did not exhibit any signs of out‑
growth through the hollow cavity, but were present only 
along its margins. In the case of spinal cords treated with 
MSCs, we found regenerating axons also in the proximi‑
ty of these cells, suggesting a permissive environment at 
least partially caused by these cells. This is supported by 
the findings of other authors reporting potential positive 
effects of MSCs on axonal regeneration (van Velthoven 
et al. 2010). A common phenomenon however, was rela‑
tively high variability between individual animals within 
groups. Considering biomaterials, other studies (Teng et 
al. 2002, Park et al. 2010) demonstrated that treatment 
Fig. 7. Quantification of astrocytes in the rostral, lesion and caudal segments of the spinal cord in the grey (I) and in the white mater (J) in intact (A‑A’), saline 
(B‑B’), alginate (C‑C’) and alginate/MSCs group (D‑D’). When comparing R, L and C segments in the grey matter, we observed gradually increasing, although 
not exclusively significant GFAP positivity in rostro‑caudal direction in all groups of animals. In the white mater, the reaction of astrocytes appeared as 
less prominent after SCI in R and C segments. Significant increase in GFAP expression was observed only in the L segment of saline treated group when 
compared to control values. Data are represented as mean ±SEM. *P<0.05, **P<0.01, ***P<0.001, one‑way ANOVA followed by Tukey‑Kramer test. (E‑H) 
representative pictures of GFAP positive cells in the grey and white matter of intact and injured animals (scale bar 25 µm). Figs (A‑D) (whole spinal cord 
sections) scale bar 1000 µm, (A’‑D’) (magnified areas from A‑D) scale bar 200 µm. 
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with cells or other components seeded on an alginate 
scaffold increased GAP‑43 expression as well as produc‑
ing significant functional improvement. According to our 
observations, despite evidently increased axonal sprout‑
ing in the group treated with both alginate and MSCs, 
increased GAP‑43 expression as a positively accepted in‑
dicator was not reflected in the behavioral improvement. 
In our future efforts, the question of axonal guidance 
through the modification of biomaterial physical proper‑
ties should be taken into account (Gunther et al. 2015b).
Reaction of astrocytes
Reactive astrogliosis, i.e. the reaction of astrocytes 
to SCI, is well documented (Fitch and Silver 2008). 
Besides its protective effect in the early stages of in‑
jury, it is believed that glial scar formation prevents 
later tissue regeneration (Silver and Miller 2004). It 
has been reported that MSCs therapy after SCI leads 
to reduction of astrocytes proliferation and inhibi‑
tion of glial scar formation (Abrams et al. 2009; Voul‑
gari‑Kokota et al. 2012) Here, we performed quantifi‑
cation of astrocytes not only in the lesion segment, but 
also in the segments above (rostral) and below (cau‑
dal) the central injury. Similarly to previous findings, 
we found that animals treated with alginate or algi‑
nate/MSCs showed slightly increased GFAP positivity 
in all three studied segments in the grey matter, but 
decreased positivity in the white matter of the lesion 
segment. Thus the therapy used in this study had only 
small influence on glial scar formation reflected in 
Fig. 8. Quantification of microglia in the rostral, lesion and caudal segments of the spinal cord in the grey matter. SCI caused increase in the number of 
microglia cells in the grey matter in each group with spinal trauma (B‑B’, C‑C’, D‑D’) compared to intact control animals (A‑A’), however without significant 
difference between these groups in both grey and white matter (H, I). (E‑G) Representative pictures of Iba‑1 positive microglia showing different morphology 
and density of cells after injury. Data are represented as mean ±SEM. *P<0.05, **P<0.01, ***P<0.001, one‑way ANOVA followed by Tukey‑Kramer test. 
Scale bar (A‑D) 1000 µm, scale bar for (A’‑D’) 200 µm. Scale bar (E‑G) 25 µm.
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GFAP expression. It is however questionable whether 
the suppression of glial scar is “good or bad”, since 
recent studies suggest that the role of astrocyte scar 
formation may be important in the process of axonal 
regeneration (Anderson et al. 2016). 
Reaction of microglia
The microglia, as a key player in CNS immunity, 
plays a crucial role in the inflammation process by re‑
leasing inflammatory cytokines, nitric oxide and oth‑
er molecules (Aloisi 2001, Block and Hong 2005). There 
is some evidence that another positive effect of MSCs 
therapy lies in its capacity to down‑regulate microglia 
activity (Kim et al. 2009, Yan et al. 2013). Our results 
show that SCI clearly causes increase in the number of 
microglia cells and change in their morphology. This 
was observed in both the grey and white matter of all 
three studied segments. Kim (2009) found that after 
co‑cultivation of LPS‑activated microglia with MSCs, 
the number of microglia cells was significantly reduced 
after a short time period (6‑24 hours). On the other 
hand, in vivo experiments with longer survival time 
have shown that MSCs could increase Iba‑1 positive cell 
expression (Lee et al. 2012). In our study we could not 
see any significant effect of alginate/MSC therapy on 
the number of microglia cells. This could probably be 
because of single and not repeated application of cells 
or a different experimental model of SCI. 
Behavioral outcomes
Several studies have produced evidence that treat‑
ment with MSCs causes locomotory improvement 
which is a crucial criterion in the evaluation of ther‑
apy efficacy (reviewed in (Oliveri et al. 2014)). On the 
contrary, according to more recent research, func‑
tional effect of MSCs is very limited or lacking (Brock 
et al. 2015, Sandner et al. 2016). In any case, it is im‑
portant to mention that there is not always a correla‑
tion between histological and behavioral outcomes. 
Some studies have yielded evidence that better loco‑
motory scores were accompanied by improved histo‑
logical outcomes such as axonal outgrowth (Cizkova 
et al. 2006, Hu et al. 2010). On the other hand, it has 
also been demonstrated that increased expression of 
markers for axonal outgrowth, in the case of GAP‑43, 
is not always linked with functional recovery, and vice 
versa (Oestreicher et al. 1997). In our study we com‑
bined classical BBB‑score open field testing with the 
more recently developed computer‑assisted Catwalk 
gait analysis system (Hamers et al. 2001). Based on 
previous studies (Joosten et al. 2004, Hendricks et al. 
2006, Koopmans et al. 2007), we chose six gait param‑
eters which could be relevant for evaluation of loco‑
motory behavior after SCI. Reflecting our histological 
data, neither the BBB‑score nor the Catwalk analysis 
showed relevant significant differences between ex‑
perimental groups. In fact, the high variability be‑
tween individual animals did not allow any conclusion 
about the positive effect of therapy at a behavioral 
level. Spinal cord injury is a very complex patholog‑
ical condition, which is to a large extent given by the 
complexity of the nervous system itself. One of the 
future therapeutic approaches could be based on the 
utilization of CNS endogenous regenerative potential 
by supporting axonal regeneration and overall recov‑
ery of lost cell populations. However, an important 
step for such a challenge is to provide a hospitable en‑
vironment in which these changes could take place. 
From this point of view, biomaterials such as alginate 
represent an interesting tool with high potential. In 
this study we have shown that the application of mes‑
enchymal stem cells seeded on alginate hydrogel pro‑
duces a supportive environment for endogenous re‑
generative processes which are reflected in increased 
axonal outgrowth. 
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